MedTrace Logo

Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone

NCT02381288 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2017-05-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effects on serum testosterone (ST) after 6 weeks of subcutaneous (SC) administration of different doses and dosing frequencies of TAK-448 to middle-aged and older men with low ST levels.

Conditions

  • Low Testosterone

Interventions

DRUG

TAK-448

TAK-448 solution for subcutaneous injection

DRUG

TAK-448 Placebo

TAK-448 placebo-matching solution for subcutaneous injection

Sponsors & Collaborators

Principal Investigators

  • Medical Director Clinical Science · Takeda

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-10
Primary Completion
2016-04-08
Completion
2016-04-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02381288 on ClinicalTrials.gov